We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Trestle and Bacus Integrate Systems

By Labmedica staff writers
Posted on 01 Jul 2005
Print article
In a move designed to provide pathologists with more options, Trestle Holdings, Inc. (Irvine, CA, USA) has partnered with Bacus Laboratories, Inc. (Chicago, IL, USA) to integrate the advanced digital microscope systems of Bacus with Trestle's suite of digital pathology workflow applications.

This agreement allows pathologists to use Trestle's Xcellerator application suite and connect it to a wider choice of digital microscopy devices. This integration marks a move away from proprietary formats, toward technical standards and open architecture intended to benefit users who have often been frustrated by the lack of interoperability among software and hardware. Bacus' viewing format offers compatibility with the microscopes used in the Nikon Coolscope VS systems as well as with Trestle's MedMicro products.

"As pathologists embrace digital devices and workflow applications, it is essential that the industry respond with improved plug-and-play compatibility so that users can derive more value from their investments in equipment,” stated Maurizio Vecchione, CEO of Trestle Holdings. "Now, pathologists can choose the optimal device for specialized forms of imaging and integrate their virtual microscopy data into one, consistent, standardized digital workflow solution.” Trestle Holdings develops and sells digital imaging and telemedicine products that link dispersed users with each other via information databases and analytical tools.

"There is now a recognized need to organize virtual slides in a meaningful and flexible way for storage and subsequent review by multiple parties,” observed Dr. James Bacus, president of Bacus Laboratories. "This agreement will allow both companies to focus on their respective areas of expertise.”





Related Links:
Trestle Holdings
Bacus Laboratories
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Tabletop Centrifuge
Mikro 185
New
Silver Member
Apolipoprotein A-I Assay
Apo A-I Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.